While some studies show that its presence is associated with resistance to anti-PD−1/PD-L1 therapy, others in colorectal cancer suggest it can enhance immunotherapeutic efficacy by increasing T cell infiltration [105]. This evidence concerns the gene CD274 and colorectal cancer.